If the sPD-L1 in peripheral blood were derived not only from cancer cells, we hypothesized that other cell types should exist that are both a source of sPD-L1 and contribute to poor prognosis in patients with NSCLC. This evidence concerns the gene SPDL1 and non-small cell lung carcinoma.